PharmaEssentia Corporation (TPE:6446)
1,240.00
-50.00 (-3.88%)
Aug 7, 2026, 1:30 PM CST
PharmaEssentia Market Cap
PharmaEssentia has a market cap or net worth of 531.79 billion as of August 7, 2026. Its market cap has increased by 213.50% in one year.
Market Cap
531.79B
Enterprise Value
508.57B
Revenue
17.50B
Ranking
n/a
PE Ratio
89.64
Stock Price
1,240.00
ChartMarket Cap Chart
Since March 11, 2014, PharmaEssentia's market cap has increased from 39.38B to 531.79B, an increase of 1,250.26%. That is a compound annual growth rate of 23.33%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 531.79B | 205.93% |
| Dec 31, 2025 | 173.83B | -15.09% |
| Dec 31, 2024 | 204.73B | 78.68% |
| Dec 29, 2023 | 114.58B | -20.34% |
| Dec 30, 2022 | 143.84B | 84.26% |
| Dec 30, 2021 | 78.07B | 215.94% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bora Pharmaceuticals | 50.50B |
| Lotus Pharmaceutical | 48.88B |
| Center Laboratories | 29.08B |
| TTY Biopharm Company | 19.05B |
| Synmosa Biopharma | 15.60B |
| ScinoPharm Taiwan | 15.06B |
| Handa Pharmaceuticals | 14.62B |
| YungShin Global Holding | 14.20B |